Trump Nominates Dr. Nicole Saphier for Surgeon General
Trump nominates radiologist Dr. Nicole Saphier as surgeon general after withdrawing Casey Means' stalled nomination.
Objective Facts
President Trump announced Thursday he is nominating former Fox News Channel contributor Dr. Nicole Saphier for surgeon general after Dr. Casey Means' path forward stalled in the Senate over questions about her experience and her stance on vaccines. Saphier is director of breast imaging at Memorial Sloan Kettering Monmouth, with a doctor of medicine degree from Ross University School of Medicine in Barbados along with fellowships at the Mayo Clinic. Health Secretary Robert F. Kennedy Jr. complimented the nomination, calling Saphier "a long-time warrior for the MAHA movement". However, Saphier has not been completely aligned with Trump on health policy, telling The Associated Press in September that his cautions about pregnant women taking Tylenol were oversimplistic and "patronizing," noting that untreated fever or severe pain can pose serious risks to mothers and babies. Saphier is the third person Trump has picked to lead the Office of the Surgeon General, after his two previous nominees failed to receive Senate support.
Left-Leaning Perspective
Left-leaning outlets focused heavily on Saphier's Fox News background as problematic. The New Republic noted that Trump announced a Fox News contributor for the position, describing her as "a STAR physician" with a career focused on breast cancer treatment. Rolling Stone investigated Saphier's attempt to trademark "Make America Healthy Again," reporting that Saphier has tried to claim ownership of the phrase despite expressing skepticism that MAHA is a panacea for American medicine, and had attempted to trademark the phrase in June 2019 before publishing her book. Left-leaning outlets raised concerns about Saphier's vaccine positions and past false claims. CBS News reported that Saphier stirred controversy when she tweeted that the CDC was preparing to mandate coronavirus vaccines for schoolchildren, a claim that was debunked by The Washington Post. The outlets also questioned whether Saphier truly represents a break from MAHA extremism. Rolling Stone quoted Saphier saying "Do I think it is the end-all be-all and going to save the health care system?" and "You can be a supporter of MAHA and not agree with every facet of it", suggesting ambivalence rather than clear opposition. Left-leaning coverage largely downplayed her criticism of Trump's Tylenol messaging and focused instead on her Fox News ties, vaccine skepticism, and business ventures selling unregulated supplements. Outlets emphasized the pattern of multiple failed Trump surgeon general nominees rather than treating Saphier as a genuine compromise.
Right-Leaning Perspective
Right-leaning coverage highlighted Saphier's stronger medical credentials compared to Means. Fox News published Trump's quotes calling Saphier "a STAR physician who has spent her career guiding women facing breast cancer through her diagnosis and treatment" and "an INCREDIBLE COMMUNICATOR, who makes complicated health issues more easily understood by all Americans". Conservative outlets emphasized that Saphier is a licensed physician unlike Means, whose license lapsed. Right-leaning sources stressed that Saphier represents a reasonable compromise acceptable to multiple constituencies. STAT News reported that some MAHA leaders appear to be getting behind the change, with Mary Talley Bowden, founder of Americans for Health Freedom, saying on social media that Saphier had "recently reached out" with "kind words". Dr. Robert W. Malone's analysis on conservative media urged MAHA supporters to withhold judgment, writing that the documentary record on Saphier is "genuinely more interesting than the press coverage has so far conveyed," pushing back on the "Fox News pick - sellout" reaction. Right-leaning coverage heavily focused on attacking Sen. Bill Cassidy for blocking Means. Calley Means wrote that he was "proud to work for the Trump admin, who has marshaled the disruptive MAHA message and driven victories against dark forces personified by Bill Cassidy". Trump-endorsed challenger Julia Letlow used the moment to attack Cassidy in her primary race.
Deep Dive
Means' withdrawal came after her tense exchanges with lawmakers of both parties threw into question whether she could secure enough votes to advance out of the Senate health committee. In an interview Thursday, Means said her nomination fell apart after a "yearlong smear campaign against me," which she said was a larger effort to impugn the MAHA movement and its focus on reforming food and healthcare. This context matters because Trump's nomination of Saphier, while presented as a fresh start, actually reflects the same underlying conflict: whether the surgeon general should be a prominent advocate for the MAHA movement or a more traditional medical leader focused on building public trust. What the opposing sides each get right and omit: Left-leaning outlets correctly identify that Saphier remains aligned with MAHA-adjacent positions on food policy and vaccine skepticism, and they appropriately flagged her false claim about CDC vaccine mandates. However, they downplayed that Saphier holds a valid medical license and has clinical experience—meaningfully different from Means—and they gave insufficient weight to her explicit disagreement with Trump on the Tylenol issue. Right-leaning supporters correctly note Saphier's stronger credentials and her willingness to dissent from Trump on at least one major issue, but they minimize her continuing skepticism about childhood vaccines and her past false claims about government vaccine mandates, and they avoid engaging seriously with concerns about the Fox News pipeline to cabinet positions. The switch signals the limits of President Trump's power to achieve Senate approval, especially after months of concerns from lawmakers about his health agenda. The critical question ahead is whether Saphier's nomination to the Senate will generate the same vaccine-related scrutiny that derailed Means, or whether her active medical license and expressed willingness to disagree with Trump will enable confirmation. Saphier's nomination will now head to Congress for consideration from the Senate Health, Education, Labor and Pensions Committee, and if the committee successfully backs the nomination, it will then move to the Senate floor for a full confirmation vote. The outcome will clarify whether the Senate opposition to Means was about her specific credential gaps or about fundamental disagreement with Trump's MAHA health agenda.